These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23076610)

  • 1. Therapeutic monitoring of escitalopram by dexamethasone suppression test.
    Lozano-Ortiz R; Marin-Lacasa R; Pascual-Garcia A; Santacruz-Abion MJ; Sebastian-Perez F; Orea-Ramón B
    Actas Esp Psiquiatr; 2012; 40(5):275-80. PubMed ID: 23076610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
    Knorr UB
    Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific effects of escitalopram on neuroendocrine response.
    Hawken ER; Owen JA; Hudson RW; Delva NJ
    Psychopharmacology (Berl); 2009 Nov; 207(1):27-34. PubMed ID: 19662384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Cytochrome P450 (CYP) 2C19 Genotypes on Steady-State Plasma Concentrations of Escitalopram and its Desmethyl Metabolite in Japanese Patients With Depression.
    Tsuchimine S; Ochi S; Tajiri M; Suzuki Y; Sugawara N; Inoue Y; Yasui-Furukori N
    Ther Drug Monit; 2018 Jun; 40(3):356-361. PubMed ID: 29570504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a retrospective claims database analysis of differences in antidepressant treatment persistence associated with escitalopram and other selective serotonin reuptake inhibitors in the United States.
    Esposito D; Wahl P; Daniel G; Stoto MA; Erder MH; Croghan TW
    Clin Ther; 2009 Mar; 31(3):644-56. PubMed ID: 19393855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram.
    Aronson S; Delgado P
    Drugs Today (Barc); 2004 Feb; 40(2):121-31. PubMed ID: 15045034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Escitalopram.
    Burke WJ
    Expert Opin Investig Drugs; 2002 Oct; 11(10):1477-86. PubMed ID: 12387707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacology review of escitalopram for the treatment of depression.
    Pastoor D; Gobburu J
    Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):121-8. PubMed ID: 24289655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of Abnormal Dexamethasone Suppression Test is Enhanced With Use of Synchronous Free Cortisol Assessment.
    Genere N; Kaur RJ; Athimulam S; Thomas MA; Nippoldt T; Van Norman M; Singh R; Grebe S; Bancos I
    J Clin Endocrinol Metab; 2022 Feb; 107(3):e1221-e1230. PubMed ID: 34648626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale and design of the participant, investigator, observer, and data-analyst-blinded randomized AGENDA trial on associations between gene-polymorphisms, endophenotypes for depression and antidepressive intervention: the effect of escitalopram versus placebo on the combined dexamethasone-corticotrophine releasing hormone test and other potential endophenotypes in healthy first-degree relatives of persons with depression.
    Knorr U; Vinberg M; Klose M; Feldt-Rasmussen U; Hilsted L; Gade A; Haastrup E; Paulson O; Wetterslev J; Gluud C; Gether U; Kessing L
    Trials; 2009 Aug; 10():66. PubMed ID: 19671139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escitalopram in the treatment of major depressive disorder: a meta-analysis.
    Kennedy SH; Andersen HF; Thase ME
    Curr Med Res Opin; 2009 Jan; 25(1):161-75. PubMed ID: 19210149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.
    Lepola UM; Loft H; Reines EH
    Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escitalopram (Lexapro) for depression.
    Masilamani S; Ruppelt SC
    Am Fam Physician; 2003 Dec; 68(11):2235-6. PubMed ID: 14677669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive Symptoms in Stroke Patients: Are There Sex Differences?
    Lee EJ; Kim JS; Chang DI; Park JH; Ahn SH; Cha JK; Heo JH; Sohn SI; Lee BC; Kim DE; Kim HY; Kim S; Kwon DY; Kim J; Seo WK; Lee J; Park SW; Koh SH; Kim JY; Choi-Kwon S
    Cerebrovasc Dis; 2020; 49(1):19-25. PubMed ID: 32023608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A new quality of the therapy of anxiety and depression--escitalopram].
    Neznanov NG; Bortsov AV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(2):79-84. PubMed ID: 15792148
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram-associated serotonin toxicity.
    Vari G; Beckson M
    J Clin Psychopharmacol; 2007 Apr; 27(2):229-30. PubMed ID: 17414259
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of citalopram on the HPA system. A study of the combined DEX/CRH test in 30 unipolar depressed patients.
    Bschor T; Ising M; Erbe S; Winkelmann P; Ritter D; Uhr M; Lewitzka U
    J Psychiatr Res; 2012 Jan; 46(1):111-7. PubMed ID: 22030468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early non-response in patients with severe depression: escitalopram up-titration versus switch to duloxetine.
    Bose A; Tsai J; Li D
    Clin Drug Investig; 2012 Jun; 32(6):373-85. PubMed ID: 22559255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.